Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH possibility

.Novo Nordisk has actually axed its own once-monthly dual GLP-1/ GIP receptor agonist, ending (PDF) ...

Daiichi pays out Merck $170M to develop bronchi cancer T-cell engager pact

.Merck &amp Co. has actually swiftly redeemed a number of the costs of its own Javelin Therapies pur...

BioMarin standstills preclinical genetics therapy for heart disease

.After BioMarin conducted a springtime well-maintained of its own pipe in April, the business has ac...

Eisai vegetations molecular adhesive SEED with $1.5 B biobucks handle

.Major Pharmas continue to be caught to the concept of molecular glue degraders. The current firm to...

Life scientific research credit report agency unveils along with $600M

.A brand-new global lifestyle scientific research credit score agency, nicknamed Symbiotic Financing...

BMS channels TIGIT, bowing out $200M bet on Agenus bispecific

.Bristol Myers Squibb is axing an additional huge wager from the Caforio era, canceling a deal for A...

Nuvation stops wager prevention after considering period 1 record

.After having a look at stage 1 data, Nuvation Biography has decided to halt work on its own single ...

' Medical intuitiveness' led FDA advisors to back Zevra's uncommon illness med

.Zevra Rehabs' unusual ailment drug seems to be to become on the path to permission this autumn afte...

Pfizer takes $230M struck after axing stopped working DMD genetics therapy

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) genetics therapy breakdown has gone a $230 thousan...

AC Immune observes 'landmark' potential in Alzheimer's medication records

.After much more than twenty years of work on neurodegenerative diseases, Swiss biotech AC Invulnera...